The @formationbio has launched a $600 million fund to acquire drug assets that pharmaceutical companies shelved for commercial rather than scientific reasons, and to move 10 to 15 Phase 1 & Phase 2 programs towards approval.
Read the @Forbes article here:
forbes.com/sites/innovationr…
Longer, healthier lives have implications for financial planning. Join our CEO Joshua Herring and Bridget Venus Grimes, Founder of @EquitaFn, for “Rethinking Financial Planning for Longer, Healthier Lives” on Dec 2 at 4:00 PM EST:
zoom.us/webinar/register/341…
“Natural” doesn’t mean safe. Our latest Hype vs. Reality article explores experimental #peptides, gaps in human safety data, risks from unregulated products, and what we know about GLP-1 medicines. #longevitylongevity.foundation/tpost/j…
AI can find a new drug candidate in days. So why does it take years to reach you?
@biogerontology says people “overestimate the capabilities of AI and underestimate the complexity of biology.” For some conditions, trials still take a decade.
That gap is now on @OpenAI's radar. This week, it bought Orchestra Bio, which uses AI agents to keep drug programmes on track.
Long-overdue study of menopause reveals it begins more than a decade before the final period. Uri Alon and collaborators analyze 300 million tests and use a mathematical technique from astronomy to shows HRT can delay many deleterious changes 🧵
Peptides are being widely discussed, but how strong is the science?
Our latest Hype vs. Reality article explores GLP-1 medicines, separating established clinical evidence from promising but preliminary findings.
Read more: longevity.foundation/tpost/0…#peptides#GLP1#longevity
Day 1 of #ARDD2026 opens at Harvard. George Daley, Dean of Harvard Medical School, kicks off the 13th Aging Research & Drug Discovery Meeting. Full program: agingpharma.org/program2026
Peptides are everywhere in conversations about weight loss, recovery, skin health, metabolism, and #longevity. But what are they, really? Our article explores what #peptides are, how they work, and how to separate science from hype.
Read more: longevity.foundation/tpost/2…